Heron Therapeutics (HRTX) FCF Margin Growth (1y) (2018 - 2026)
Heron Therapeutics (HRTX) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Heron Therapeutics |
85.57 Mn |
55.60 Mn |
24.07 Mn |
1,752.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
1,752.00 |
| Dec 31, 2025 |
782.00 |
| Sep 30, 2025 |
-548.00 |
| Jun 30, 2025 |
-1,699.00 |
| Mar 31, 2025 |
437.00 |
| Dec 31, 2024 |
-3,689.00 |
| Sep 30, 2024 |
4,068.00 |
| Jun 30, 2024 |
7,362.00 |
| Mar 31, 2024 |
5,739.00 |
| Dec 31, 2023 |
13,282.00 |
| Sep 30, 2023 |
10,802.00 |
| Jun 30, 2023 |
1,745.00 |
| Mar 31, 2023 |
10,693.00 |
| Dec 31, 2022 |
9,463.00 |
| Sep 30, 2022 |
9,572.00 |
| Jun 30, 2022 |
17,822.00 |
| Mar 31, 2022 |
2,166.00 |
| Dec 31, 2021 |
4,616.00 |
| Sep 30, 2021 |
-2,203.00 |
| Jun 30, 2021 |
-2,646.00 |
